Related Experiment Videos
PPAR delta: an uncompletely known nuclear receptor
1INSERM, U 636, Centre de Biochimie, UFR Sciences, Parc Valrose, Université de Nice-Sophia-Antipolis, Nice, F-06108 France. fredenrich.a@chu-nice.fr
Diabetes & Metabolism
|April 2, 2005
Summary
Peroxisome proliferator-activated receptor delta (PPARδ) enhances fatty acid oxidation in skeletal muscle, reducing adipose mass. This highlights PPARδ
Area of Science:
- Metabolic research
- Molecular biology
- Endocrinology
Background:
- Peroxisome proliferator-activated receptors (PPAR) are key regulators of metabolism and development.
- Three isotypes exist: PPARα, PPARγ, and PPARδ, with known roles for PPARα (lipid normalization) and PPARγ (antidiabetic drugs).
- The functions of PPARδ are less understood but involve fatty acid oxidation regulation.
Purpose of the Study:
- To elucidate the role of PPARδ in metabolic regulation, particularly in response to high-fat diets.
- To investigate the impact of PPARδ on fatty acid metabolism and adipose tissue function.
Main Methods:
- Utilized a transgenic murine model with PPARδ overexpression.
- Analyzed changes in muscle oxidative capacity and fatty acid flux.
- Assessed adipose tissue mass and adipocyte size.
Main Results:
- PPARδ overexpression increased skeletal muscle oxidative capability.
- Fatty acid flux was redirected from adipose tissue to skeletal muscle.
- Adipose mass was reduced due to decreased adipocyte size, suggesting a role in adapting to high-fat diets.
Conclusions:
- PPARδ plays a significant role in metabolic adaptation to high-fat diets.
- PPARδ, PPARα, and PPARγ likely have complementary roles in obesity and metabolic syndrome.
- Combined PPAR agonist therapies may offer future therapeutic benefits for metabolic disorders.